Seminars in Thrombosis and Hemostasis

Article	Citations
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues	76
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	73
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review	53
Hemostasis from Bench to Bedside: The History of Three Successful Stories of Translational Medicine	46
	43
Altered Fibrinolysis during and after Surgery	32
Three-Dimensional Human Neural Stem Cell Models to Mimic Heparan Sulfate Proteoglycans and the Neural Niche	31
Pregnancy Related Venous Thromboembolism-Associated with HIV Infection and Antiretroviral Therapy	31
Mechanical Heart Valves, Pregnancy, and Bleeding: A Systematic Review and Meta-Analysis	30
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease	30
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	27
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	24
Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions	22
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States	22
Cardiovascular Oncology: The Need for a Multidisciplinary Approach	22
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	22
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	21
Erratum: Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome	21
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III	20
	20
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	19
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II	19
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review	19
Dedication to Santa Maria Favaloro (1926–2022)	19
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	19

Cerebral Venous Thrombosis	18
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	18
Heparin: The Journey from Parenteral Agent to Nasal Delivery	18
Response to “Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease”	18
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	18
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	17
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	17
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	17
A Historical Perspective on the Reversal of Anticoagulants	16
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders	16
Gene Therapy for Inherited Bleeding Disorders	16
The Art and Science of Building a Computational Model to Understand Hemostasis	16
	15
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis	15
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients	15
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition	15
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis	14
The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application	14
Mean Platelet Volume Predicts Severe COVID-19 Illness	14
Trousseau's Syndrome in 19th Century Qing Dynasty Paintings of Breast Tumors: Early Insights into Cancer and Thrombosis Risk	14
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	13
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	13
Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis	13
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	13
Catastrophic Thrombosis: A Narrative Review	13
The Impact of Emotional Responses on Female Reproduction: Fibrinolysis in the Spotlight	13
Advances in the Management of Cancer-Associated Thrombosis	13
What Role Does Microthrombosis Play in Long COVID?	13
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	12
Bleeding Scoring Systems in Neonates: A Systematic Review	12
Sticky Platelet Syndrome Revisited?	12
Role of Platelets and Their Interaction with Immune Cells in Venous Thromboembolism	12
Platelet-Type von Willebrand Disease: Complex Pathophysiology and Insights on Novel Therapeutic and Diagnostic Strategies	12
Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders	12
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	12
Inhibitors of Polyphosphate and Neutrophil Extracellular Traps	12
Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions	12
Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIa	11
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	11
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	11
Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents	11
The Role of CD36/GPIV in Platelet Biology	11
The History of Factor XIII Deficiency	11
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	11
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	11
Fibrin Clot Properties in Cancer: Impact on Cancer-Associated Thrombosis	11
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	11
Thromboembolic Complications in Takotsubo Cardiomyopathy	11
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	10
Russell Viper Venom: A Journey from the Bedside to the Bench and Back to the Bedside	10

Novel Insights into Heterozygous Factor XIII Deficiency	10
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	10
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom	10
Editorial Compilation XIV	10
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	10
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	10
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	10
Erratum: Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden	9
Development of Molecules Antagonizing Heparan Sulfate Proteoglycans	9
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	9
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients	9
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	9
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease	9
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System	9
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis	9
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review	9
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years	9
Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies	9
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	9
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization	9
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	8
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	8
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	8
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	8
The Role of Fibrin(ogen) in Wound Healing and Infection Control	8
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series	8
Heterogeneity in Bleeding Tendency and Arthropathy Development in Individuals with Hemophilia	8
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	8
	8
Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders	8
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review	8
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	8
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More	8
Venous Thromboembolism among Critically Ill Children: A Narrative Review	8
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19	7
	7
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	7
Hereditary Hemorrhagic Telangiectasia: On the Brink of a New Treatment Era?	7
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties	7
Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review	7
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology	7
Gastrointestinal Bleeding in Congenital Bleeding Disorders	7
Editorial Compilation XI	7
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	7
Inflammation and Coagulation in Neurologic and Psychiatric Disorders	7
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	7
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment	7
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?	7
	7
Erratum: Septic Pulmonary Embolism. A Contemporary Profile	7
Arterial Thrombosis in Cancer Patients: An Update	7
Platelet Activation and Thrombosis in COVID-19	7
The Most Highly Downloaded Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 10 Years in the Making	6
	6
Blood Rheology and Hemodynamics	6
Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part I	6
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	6
New Seminars in Thrombosis and Hemostasis 2022 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	6
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation	6
Recent Advances in Thrombosis and Hemostasis—Part VII	6
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	6
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	6
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	6
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia	6
Platelet Function Testing: Update and Future Directions	6
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	6
Description of an In Vitro Platelet Function Analyzer—PFA-100™	6
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	6
Contraceptives and Thrombosis: An Intertwined Revolutionary Road	6
Development of a Coagulation Disorders Unit	6
The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism	6
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	6
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice	6
Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII	5
Platelet Physiology	5
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	5
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)	5
Precision Medicine in Rare Bleeding Disorders	5
Laboratory and Molecular Diagnosis of Factor XI Deficiency	5
Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K–Dependent Coagulation Factors Deficiency	5

Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	5
The Role of Myeloid Cells in Thromboinflammatory Disease	5
Heparin and Posttraumatic Stress Disorder	5
Factor XII Structure–Function Relationships	5
Blood Rheology and Hemodynamics: Still Illuminating after 20 Years	5
Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review	5
Whole Blood Viscosity and Cerebral Blood Flow in Acute Ischemic Stroke	5
Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Literature Review and Description of Local Case in a 3-Year-Old Chinese Girl	5
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	5
Testing for Lupus Anticoagulants	5
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	5
	5
Platelets: Physiology and Biochemistry	5
ABO Blood Group and the Risk of Thrombosis in Cancer Patients: A Mini-Review	5
Platelet Pathophysiology: Unexpected New Research Directions	5
VEXAS Syndrome and Thrombosis: Findings of Inflammation, Hypercoagulability, and Endothelial Dysfunction	5
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	5
Thrombin: A Pivotal Player in Hemostasis and Beyond	5
	5
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	5
Thrombophilia Screening: Not So Straightforward	5
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	5
A Critical Reappraisal of the Bleeding Time	5
Welcome to Seminars in Thrombosis & Hemostasis 2023	4
Endothelial Heparan Sulfate Proteoglycans in Sepsis: The Role of the Glycocalyx	4
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	4
The Fibrinolytic System in Peripartum Depression	4
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	4
Venous Thromboembolism among Noncritically Ill Hospitalized Children: Key Considerations for the Pediatric Hospital Medicine Specialist	4
The Role of Platelets in Atherosclerosis: A Historical Review	4
Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans	4
Outcome of Major Hemorrhage at a Major Cardiothoracic Center in Patients with Activated Major Hemorrhage Protocol versus Nonactivated Protocol	4
	4
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger	4
Venous Thromboembolism in Premature Neonates	4
The Contribution of Seminars in Thrombosis and Hemostasis beyond the Academic Community	4
	4
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data	4
The Overlooked Risk of Venous Thromboembolism in Psychiatric Patients: Epidemiology, Pathophysiology, and Implications for Clinical Care	4
Recent Advances in Thrombosis and Hemostasis—Part VIII	4
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review	4
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	4
Erratum: A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan	4
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness	4
Editorial Compilation XII	4
Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease: Comment on “Cancers in Patients with von Willebrand Disease”	4
2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	4
Editorial Compilation—XIII	4
Safety and Efficacy of Rivaroxaban for Inferior Vena Cava Thrombosis after Successful Catheter-Directed Thrombolysis	4
	4
PKC-Delta-Dependent Pathways Contribute to the Exacerbation of the Platelet Activity in Crohn's Disease	4
	4
Planning Pregnancy and Birth in Women with Inherited Bleeding Disorders	4
Proposal for a Simple Algorithmic Approach to Manage Drug–Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients	4
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	3
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis	3
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence	3
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	3
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	3
Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease	3
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond	3
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests?—Part II: The Use of Thromboelastography and Thromboelastometry in the Assessment of Clin	3
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	3
Cancer-Associated Splanchnic Vein Thrombosis	3
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates	3
Cardiovascular Mortality after Venous Thromboembolism: A Meta-Analysis of Prospective Cohort Studies	3
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	3
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	3
The History of Rare Bleeding Disorders	3
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	3
	3
Recent Advances in Thrombosis and Hemostasis—Part X	3
Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	3
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	3
Hemostasis Testing in the Emergency Department: A Narrative Review	3
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review	3
Antiphospholipid Antibodies in Mental Disorders	3
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	3
Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients	3
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	3
Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy	3
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches	3
Fifty Years of Fibrinogen Structure and Function	3
The Most Highly Cited Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 50 Years in the Making	3
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	3
Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography	3
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	3
Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders	3
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature	3
Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study	3
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	3
Letter to the Editor: 10-Year Evolution in Worldwide Usage of Anticoagulant Drugs	3
Right Ventricular Recovery: Early and Late Changes after Acute PE Diagnosis	3
Von Willebrand Factor Multimer Analysis and Classification: A Comprehensive Review and Updates	3
Effect of Remote Ischemic Conditioning on Bleeding Complications in Surgery: A Systematic Review and Meta-Analysis	3